Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?
Saved in:
| Title: | Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis? |
|---|---|
| Authors: | Cohen JA; Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio., Cross AH; Department of Neurology, Washington University, St Louis, Missouri. |
| Source: | JAMA neurology [JAMA Neurol] 2023 Jul 01; Vol. 80 (7), pp. 669-672. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6157 |
|---|---|
| DOI: | 10.1001/jamaneurol.2023.0467 |
